Hidradenitis suppurativa burdens on mental health: a literature review of associated psychiatric disorders and their pathogenesis - Caccavale S, Tancredi V, Boccellino MP, Babino G, Fulgione E, Argenziano G.
Skin, mental health and the central nervous system (CNS) are connected by a deep link. It is not only the aesthetic and sometimes the disfiguring aspects of dermatological conditions that can cause a severe psychological burden; also, different studies hav... (Source: SafetyLit)
Source: SafetyLit - May 10, 2024 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Adalimumab Improves Blood Parameters in Patients With HS Adalimumab Improves Blood Parameters in Patients With HS
Treatment with adalimumab was associated with improvements in common hematologic abnormalities in patients with hidradenitis suppurativa, particularly in responders.Medscape Medical News (Source: Medscape Allergy Headlines)
Source: Medscape Allergy Headlines - May 9, 2024 Category: Allergy & Immunology Tags: Dermatology Clinical Summary Source Type: news

Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study Hidradenitis Suppurativa: Sonelokimab Shows Promise in Study
Sonelokimab is a novel humanized nanobody that selectively binds to interleukin (IL)-17A and IL-17F.MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 9, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa Ruxolitinib Cream Shows Promise for Hidradenitis Suppurativa
Treatment with the topical JAK inhibitor reduced abscess and inflammatory nodules in a phase 2 randomized, controlled trial in patients with mild hidradenitis suppurativa.Medscape Medical News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - April 3, 2024 Category: Dermatology Tags: Dermatology Source Type: news

Clinical Advances in Hidradenitis Suppurativa From AAD 2024 Clinical Advances in Hidradenitis Suppurativa From AAD 2024
Highlights in HS research from AAD 2024 include several novel therapeutic agents and an increased risk for health complications in children of HS mothers, as chosen by Dr Jennifer Hsiao.Medscape (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 29, 2024 Category: Consumer Health News Tags: None ReCAP Source Type: news

Hidradenitis Suppurativa in Women
Hidradenitis suppurativa is an inflammatory condition that affects more women than men. Learn how to manage it. (Source: WebMD Health)
Source: WebMD Health - March 28, 2024 Category: Consumer Health News Source Type: news

Treating Hidradenitis Suppurativa With Biologics
Thinking about treating your hidradenitis suppurativa with a biologic? Kathryn Shusta shares her experience. (Source: WebMD Health)
Source: WebMD Health - March 28, 2024 Category: Consumer Health News Source Type: news

Hidradenitis Suppurativa Responds Quickly to Novel BTK Inhibitor
(MedPage Today) -- SAN DIEGO -- An investigational Bruton's tyrosine kinase (BTK) inhibitor significantly improved hidradenitis suppurativa (HS) disease status in a randomized, placebo-controlled trial reported here. More than 70% of patients... (Source: MedPage Today Dermatology)
Source: MedPage Today Dermatology - March 11, 2024 Category: Dermatology Source Type: news

Novel Drug Shows Promise for Hidradenitis Suppurativa Novel Drug Shows Promise for Hidradenitis Suppurativa
The findings suggest that Bruton ' s tyrosine kinase inhibition may emerge as a promising therapeutic intervention in HS.Medscape Medical News (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - March 9, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news

Clinical Markers Improve With IV Ertapenem for Hidradenitis Suppurativa
WEDNESDAY, Feb. 21, 2024 -- Treatment of hidradenitis suppurativa (HS) with intravenous ertapenem is associated with improvement in clinical and inflammatory markers, according to a study published online Feb. 19 in JAMA Dermatology. Avigdor... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - February 21, 2024 Category: Pharmaceuticals Source Type: news

Factors ID'd That Affect Medical Decision-Making in Hidradenitis Suppurativa
WEDNESDAY, Jan. 17, 2024 -- Factors that affect medical decision-making among patients with hidradenitis suppurativa (HS) include suffering threshold, perceptions of treatment risk, treatment fatigue, understanding of the disease, and sources of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - January 17, 2024 Category: Pharmaceuticals Source Type: news

Tape Strips Detect Hidradenitis Suppurativa Biomarkers Tape Strips Detect Hidradenitis Suppurativa Biomarkers
" Tape strips can provide important clues to when and which drugs to use in HS in patients with both early and late disease, which can change clinical practice. "MDedge News (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - December 9, 2023 Category: Dermatology Tags: Dermatology Source Type: news

FDA Approves Novartis Cosentyx(R) as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as early as Week 21 As the only IL-17A inhibitor approved for HS, Cosentyx offers a meaningful new treatm... Biopharmaceuticals, FDA Novartis, Cosentyx, hidradenitis suppurativa (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - October 31, 2023 Category: Pharmaceuticals Source Type: news

FDA Approves Novartis' Cosentyx as the First New Biologic Treatment Option for Hidradenitis Suppurativa Patients in Nearly a Decade
FDA approval based on robust Phase III data in which Cosentyx® (secukinumab) showed rapid relief from symptoms of hidradenitis suppurativa (HS) as early as Week 21 As the only IL-17A inhibitor approved for HS, Cosentyx offers a meaningful new... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - October 31, 2023 Category: Drugs & Pharmacology Source Type: news

Crohn Disease More Common in People With Hidradenitis Suppurativa
WEDNESDAY, June 14, 2023 -- Pediatric patients with hidradenitis suppurativa (HS) have a higher prevalence of Crohn disease, according to a research letter published online June 14 in JAMA Dermatology. Nicole Mastacouris, from the Donald and Barbara... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 14, 2023 Category: Pharmaceuticals Source Type: news